Category Archives:

By Andreas Rinke FRANKFURT (Reuters) - The European Medicines Agency (EMA) does not expect to make a decision on the approval of German biotech group CureVac's COVID-19 vaccine before August, an offic...

By David Shepardson WASHINGTON (Reuters) - The U.S. Senate on Tuesday is set to approve a sweeping package of legislation intended to boost the country's ability to compete with Chinese technology, as...

(Reuters) - Inovio Pharmaceuticals Inc on Tuesday expanded its partnership with Advaccine Biopharmaceuticals to conduct a late-stage trial of its COVID-19 vaccine candidate. The company said the vacci...

AMSTERDAM (Reuters) - A judge in the Dutch murder trial over the downing of a Malaysian airliner over rebel-held eastern Ukraine in 2014 said on Tuesday there was evidence the airplane was hit by an o...

By Jane Lanhee Lee (Reuters) - Honeywell International Inc and quantum computer software startup Cambridge Quantum Computing (CQC) on Tuesday announced they will form a joint venture, integrating Hone...

(Reuters) - Aspirin does not improve the chances of survival in severely ill COVID-19 patients, early results from one of Britain's biggest trials studying the commonly used painkiller and blood thinn...

LONDON (Reuters) - British fund manager Ruffer Investment Management exited its bitcoin bet in April with a $1.1 billion profit amid worries over risk after quick gains in the cryptocurrency's price, ...

BRUSSELS (Reuters) - David Frost, the UK's minister in charge of ties with the European Union, and Maros Sefkovic, vice head of the European Commission, meet on Wednesday to try and resolve difference...

(Writes through) By Rocky Swift and Sakura Murakami TOKYO (Reuters) - Japan's 2020 Olympics committee may seek further vaccine donations to make the rescheduled Games as safe as possible, Tokyo 2020's...

LONDON (Reuters) - Britain urged the European Union on Tuesday to help find an urgent solution to trade difficulties with Northern Ireland before the end of this month, saying there was no case for th...